Douglas E. Giordano does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Zoetis Inc., Viatris Inc, Panacea Acquisition Corp. II, ICU MEDICAL INC/DE, Cerevel Therapeutics Holdings, Inc., KING PHARMACEUTICALS INC, ICAGEN INC, and ENCYSIVE PHARMACEUTICALS INC.

2023 was Douglas E. Giordano's most active year for acquiring shares with 2 total transactions. Douglas E. Giordano's most active month to acquire stocks was the month of May. 2024 was Douglas E. Giordano's most active year for disposing of shares, totalling 3 transactions. Douglas E. Giordano's most active month to dispose stocks was the month of July. 2013 saw Douglas E. Giordano paying a total of $130,000.00 for 5,000 shares, this is the most they've acquired in one year. In 2024 Douglas E. Giordano cashed out on 108,985 shares for a total of $0.00, their largest year based on trade value.